Emerson Peter, Van Haeften Timon W, Pimenta Walkyria, Plummer Elena, Woerle Hans J, Mitrakou Asimina, Szoke Ervin, Gerich John, Meyer Christian
Department of Endocrinology, Carl T Hayden VA Medical Center, Phoenix, AZ 85012, USA.
Metabolism. 2009 May;58(5):602-7. doi: 10.1016/j.metabol.2008.12.004.
To assess whether an increased genetic predisposition for type 2 diabetes mellitus (T2DM) influences the contributions of insulin resistance and impaired insulin secretion to impaired glucose tolerance (IGT), 437 subjects not known to have T2DM underwent an oral glucose tolerance test and a 3-hour hyperglycemic clamp. Plasma insulin responses and insulin sensitivity were compared between all subjects (unselected for demographic or anthropometric characteristics) who had normal glucose homeostasis and no first-degree T2DM relative (n = 133), IGT with a first-degree T2DM relative (IGT/FH+, n = 74), or IGT without a first-degree T2DM relative (IGT/FH-, n = 50). Compared with those with normal glucose homeostasis, first- and second-phase plasma insulin responses were reduced approximately 45% and 30%, respectively (both P < .001), in IGT/FH+, whereas insulin sensitivity was only approximately 20% reduced (P = .011). In contrast, in IGT/FH-, first-phase plasma insulin responses were only approximately 20% reduced (P = .016), second-phase plasma insulin responses were not reduced, but insulin sensitivity was approximately 40% reduced (P < .001). The IGT/FH+ group differed significantly from the IGT/FH- group by having 25% to 30% lower first-phase plasma insulin responses (P = .026) and 25% to 30% greater insulin sensitivity (P = .027). Adjustment for obesity abolished the differences in insulin resistance but not plasma insulin responses. However, when the IGT groups were stratified into subgroups based on body mass index (BMI), first-phase plasma insulin responses were approximately 30% lower in IGT/FH+ with a BMI of at least 27 kg/m(2) (P = .018) but similar in IGT/FH+ with a BMI less than 27 kg/m(2) compared with the corresponding IGT/FH- subgroups. We conclude that, in IGT, an increased genetic predisposition for T2DM increases the contribution of impaired insulin secretion to its pathophysiology. This effect is enhanced by obesity.
为评估2型糖尿病(T2DM)遗传易感性增加是否会影响胰岛素抵抗和胰岛素分泌受损对糖耐量受损(IGT)的作用,437名未知患有T2DM的受试者接受了口服葡萄糖耐量试验和3小时高血糖钳夹试验。比较了所有血糖稳态正常且无一级T2DM亲属的受试者(未根据人口统计学或人体测量学特征进行选择,n = 133)、有一级T2DM亲属的IGT患者(IGT/FH+,n = 74)或无一级T2DM亲属的IGT患者(IGT/FH-,n = 50)的血浆胰岛素反应和胰岛素敏感性。与血糖稳态正常的受试者相比,IGT/FH+组的第一相和第二相血浆胰岛素反应分别降低了约45%和30%(均P <.001),而胰岛素敏感性仅降低了约20%(P =.011)。相比之下,在IGT/FH-组中,第一相血浆胰岛素反应仅降低了约20%(P =.016),第二相血浆胰岛素反应未降低,但胰岛素敏感性降低了约40%(P <.001)。IGT/FH+组与IGT/FH-组的显著差异在于,其第一相血浆胰岛素反应低25%至30%(P =.026),胰岛素敏感性高25%至30%(P =.027)。对肥胖进行校正消除了胰岛素抵抗的差异,但未消除血浆胰岛素反应的差异。然而,当根据体重指数(BMI)将IGT组分层为亚组时,BMI至少为27 kg/m²的IGT/FH+组的第一相血浆胰岛素反应降低了约30%(P =.018),而BMI小于27 kg/m²的IGT/FH+组与相应的IGT/FH-亚组相比则相似。我们得出结论,在IGT中,T2DM遗传易感性增加会增加胰岛素分泌受损对其病理生理学的作用。肥胖会增强这种效应。